Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) fell 19.6% on Saturday . The company traded as low as C$0.18 and last traded at C$0.19. 802,183 shares traded hands during trading, an increase of 866% from the average session volume of 83,002 shares. The stock had previously closed at C$0.23.
Nanalysis Scientific Price Performance
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The firm has a market capitalization of C$20.95 million, a price-to-earnings ratio of -1.68 and a beta of -0.75. The business has a fifty day moving average of C$0.24 and a two-hundred day moving average of C$0.27.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Read More
- Five stocks we like better than Nanalysis Scientific
- What Do S&P 500 Stocks Tell Investors About the Market?
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
- Airline Stocks – Top Airline Stocks to Buy Now
- Tencent Music Stock Outshines Spotify as China’s Music Giant
- There Are Different Types of Stock To Invest In
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
